Optimization of iontophoretic parameters for the transdermal delivery of methotrexate

被引:6
|
作者
Vemulapalli, Viswatej [1 ]
Banga, Ajay K. [1 ]
Friden, Phillip M. [2 ]
机构
[1] Mercer Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Atlanta, GA 30341 USA
[2] Transport Pharmaceut Inc, Framingham, MA USA
关键词
factorial design; iontophoresis; methotrexate; transdermal drug delivery;
D O I
10.1080/10717540802035145
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to study the in vitro factors affecting transdermal iontophoretic delivery of methotrexate across hairless rat skin. Initial screening studies evaluated the effect of ionic strength and donor concentration. A response surface model using factorial design shows an increase in the cumulative amount of methotrexate delivered (Y1) with an increase in current density (X1) and time of application (X2). However, 10 min iontophoresis and 0.05 mA/cm2 current density did not show an increase in delivery with an increase in current density or time of application, respectively. The factorial design was able to identify the optimal parameters that would have been difficult to predict with a conventional one at a time-experimental approach.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 50 条
  • [21] Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery
    Wang, YP
    Thakur, R
    Fan, QX
    Michniak, B
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (02) : 179 - 191
  • [22] Biodegradable Mg Electrodes for Iontophoretic Transdermal Drug Delivery
    Jeong, Goeen
    Han, Hyung-Seop
    Jeon, Hojeong
    Kim, Yu-Chan
    Jang, Ho Won
    Ok, Myoung-Ryul
    METALS AND MATERIALS INTERNATIONAL, 2023, 29 (07) : 2084 - 2092
  • [23] IONTOPHORETIC (TRANSDERMAL) DELIVERY OF DRUGS - OVERVIEW OF HISTORICAL DEVELOPMENT
    CHIEN, YW
    BANGA, AK
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (05) : 353 - 354
  • [24] Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate
    Kolli, Chandra Sekhar
    Xiao, Jin
    Parsons, Daniel L.
    Babu, R. Jayachandra
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (05) : 571 - 576
  • [25] Iontophoretic transdermal delivery of angiotensin II and its antagonists
    Huang, Yi-You
    Biomedical Engineering - Applications, Basis and Communications, 2001, 13 (05): : 242 - 247
  • [26] Transdermal iontophoretic delivery of insulin using a photoetched microdevice
    Haga, M
    Akatani, M
    Kikuchi, J
    Ueno, Y
    Hayashi, M
    JOURNAL OF CONTROLLED RELEASE, 1997, 43 (2-3) : 139 - 149
  • [27] A unique iontophoretic patch for optimal transdermal delivery of sumatriptan
    Siegel, Steven J.
    Neill, Carol O.
    Dube, Louise M.
    Kaldeway, Peter
    Morris, Russell
    Jackson, David
    Sebree, Terri
    PHARMACEUTICAL RESEARCH, 2007, 24 (10) : 1919 - 1926
  • [28] Transdermal iontophoretic delivery of celecoxib from gel formulation
    Tavakoli, Naser
    Minaiyan, Mohsen
    Heshmatipour, Mojtaba
    Musavinasab, Ruholla
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2015, 10 (05) : 419 - 428
  • [29] CHARACTERIZATION OF IN-VITRO TRANSDERMAL IONTOPHORETIC DELIVERY OF INSULIN
    BANGA, AK
    CHIEN, YW
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (16) : 2069 - 2087
  • [30] Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions
    Chang, SL
    Banga, AK
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (06) : 635 - 640